← Browse by Condition
Medical Condition
chronic pelvic pain
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 3
Pain clinical trials span acute procedural pain, chronic musculoskeletal pain, neuropathic pain, and cancer-related pain β€” each requiring distinct trial designs and patient-reported outcome instruments. The regulatory demand for non-opioid alternatives has intensified the search for novel analgesic mechanisms, particularly ion channel targets and neurostimulation approaches.
Active trials evaluate Nav1.7/1.8 blockers, CGRP antagonists for new indications, spinal cord stimulation refinements, virtual reality-based pain management, and patient-specific ketamine infusion protocols. Pain trials increasingly use ecological momentary assessment (EMA) diary approaches over traditional recall-based pain rating scales.
Frequently Asked Questions — chronic pelvic pain Clinical Trials
How many clinical trials are currently recruiting for chronic pelvic pain?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for chronic pelvic pain, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for chronic pelvic pain?
chronic pelvic pain research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a chronic pelvic pain clinical trial?
Eligibility criteria for chronic pelvic pain trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06885931
Recruiting
Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)
Enrollment
86 pts
Location
Belgium, Netherlands...
Sponsor
Amber Therapeutics Ltd
NCT05324280
Recruiting
Acupuncture in a Multidisciplinary Approach for Vulvodynia and Chronic Pelvic Pain
Enrollment
68 pts
Location
Austria
Sponsor
Medical University of Graz
NCT06995287 Phase 3
Recruiting
Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea
Enrollment
222 pts
Location
France
Sponsor
Nantes University Hospital
NCT06778070
Recruiting
National Program to Overcome Pelvic Pain studY (POPPY)
Enrollment
220 pts
Location
United States
Sponsor
University of California, San ...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology